An enzyme-linked immunosorbent assay for immunoglobulin G antibody to encephalomyocarditis virus was developed. This assay was comparable to antibody assay by neutralization. Its adaptability should be useful for laboratory and epidemiological studies of infections due to encephalomyocarditis virus.
Infections due to encephalomyocarditis (EMO) virus are widespread in nature (11) . AIthough this virus is considered to be primarily an infectious agent ofrodents, infections of other vertebrates, including humans, occur (1, (9) (10) (11) . EMC virus has been isolated from humans, nonhuman primates, and other mammals and has been associated with a number of epizootics in domestic animals (5, 6, 8) . Several strains of EMC virus have been isolated which are closely related antigenically, but differ in the pathogenesis of infection that they produce (4, 11) . One of these strains, the M strain of EMC virus (EMC-M), has been the focus of recent interest because of its propensity to cause diabetes in certain strains of mice (3) . During recent studies ofmurine infection due to EMC-M we developed a simple enzyme-linked immunosorbent assay (ELISA) to detect immunoglobulin G (IgG) antibody to this agent.
MATERIAIS AND METHODS
Mice. BALB/c mice (Charles River Breeding Laboratories, Inc., Wilmington, Mass.) were used throughout these studies.
Cell culture method. Primary mouse embryo fibroblast (MEF) monolayers prepared by trypsin-ethylenediaminetetraacetic acid dissociation of embryos of late-term pregnant mice were maintained in Eagle minimum essential medium containing 10% newborn calf serum, penicillin (100 U/ml), and streptomycin (100 pg/ml). Quantitation of virus was performed by plaque assay in MEF monolayers under tragacanth overlay (10) .
Virus. For these studies, EMC-M was kindly supplied by A. Notkins (National Institutes of Health, Bethesda, Md.) Another strain of EMC virus, the Helwig prototype strain, was obtained from the American Type Culture Collection (Rockville, Md.) (ATCC VR 129). Virus stocks were prepared by infecting MEF monolayers. After 48 h, cell lysates prepared by three freeze-thaw cycles were clarified by centrifugation at 10,000 x g for 30 min at 4°C and stored in Eagle miniimum essential medium plus 5% newborn calf serum at -70°C. The titers of the stock virus pools for both EMC-M and the prototype strain were 2 x 106 plaque-forming units per ml.
Experimental infection ofmice. Mice inoculated with 500 plaque-forming units of EMC-M intraperitoneally were killed and eniated at various intervals after infection. Uninfected mice served as controls. Serum was collected, heated at 560C for 30 min, and stored at -20°C. The globulin fraction of normal mouse serum was prepared by two cycles of (NH4)2SO0 precipitation followed by dialysis using 0.01 M phosphate-buffered 0.15 M saline (PBS), pH 7.4 (7).
PRNT amay. Antibody to EMC was determined by plaque reduction neutralization (PRNT) assay as described by Tesh and Wallace (10) . The highest dilution of serum producing a o90% plaque reduction was recorded as the titer endpoint.
Preparation of EMC antigen for the ELISA. Viral antigens for both the M and prototype strains for the ELISA were prepared by inoculating 75-cm2 MEF monolayers with a 10-4 dilution of stock virus. Control antigens were simultaneously prepared from mock-infected cell monolayers. After adsorption and washing, the cells were maintained at 37°C in Eagle minimum essential medium containing no newborn calf serum until complete destruction of the cells had occurred, usually 2 days. After three freeze-thaw cycles and clarification by centrifugation at 10,000 x g for 30 min, supernatant fluids were then centrifuged for 4 h at 130,000 x g at 40C in a Beckman L5-50 ultracentrifuge. The virus pellet was suspended in 0.06 M carbonate buffer (pH 9.6) at 1/20 the original volume and stored at -20°C in glass vials. The viral antigens were stable, despite freeze-thawing, for up to 6 months.
To prepare the solid-phase antigens for the ELISA, 0.2-ml samples of viral or control antigen diluted in 0.06 M carbonate buffer (pH 9.6) were incubated over- ELISA procedure. The ELISA procedure followed the basic format of Bidwell et al. (2) . At the initiation of the antibody assay, the antigen was removed, and the plates were washed three times in PBS (pH 7.4) with 0.05% Tween-20 (PBS-T). Serum Since various strains of EMC virus have been shown to cross-react in both hemagglutination inhibition and neutralization assays, antigen for the prototype strain of EMC virus was tested by ELISA assay for reaction with immune serum to EMC-M. The ELISA reaction of the prototype strain with both immune and normal mouse serum was identical to that of the EMC-M antigen run in parallel. These results indicate that the cross-reaction of strains of EMC virus seen in other assay systems also occurs in this ELISA.
ELISA reaction of sera lacking antibody to EMC-M virus. The range of colorimetric reaction of EMC antibody-negative sera was determined in order to establish reliable criteria to identify sera containing antibody to EMC virus. Twenty-one sera with neutralizing antibody titers of <1:20 were evaluated by ELISA reaction, using both EMC-M and control antigens. Figure 2 shows the distribution of absorbance values of these samples against EMC-M antigen. The mean absorbance was 0.077 ± 0.025. For the control antigen the mean value was 0.055 ± 0.020. An absorbance value of 0.127, 2 standard deviations from the mean, was selected as a cut-off value to identify EMC-M antibody-negative sera. Using this value, only 1 of 21 sera would have been incorrectly categorized.
Comparison of ELISA and PRNT assays for antibody to EMC-M virus. The ability of the ELISA to identify sera containing antibody to EMC-M virus was compared to that of the PRNT test. A total of 37 sera was evaluated in both systems. In addition to the 21 sera derived from uninfected mice, 16 sera obtained from animals >1 month after infection were tested. The results of these comparative titrations (Fig.   3 ) indicate a good correlation of these two methods (r = 0.91). Of 16 sera from previously infected animals, 14 were antibody positive in both assay systems. Two sera from convalescent mice were reactive by PRNT at 1:40 and 1:80, but nonreactive by ELISA. One of the 21 sera nonreactive by PRNT was reactive in the ELISA. In general, the antibody titers obtained by PRNT were higher than those in the ELISA.
DISCUSSION
In the past, serological testing for antibody to EMC virus has relied primarily on either hemagglutination inhibition or virus neutralization assays. In this paper, we 
